Drugs / Quadrivalent VLP Vaccine
Quadrivalent VLP Vaccine
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01991587 | Oct 2013 → Jun 2014 | respiratory tract infectious disorder, viral infectious disease | Medicago | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT02831751 | Apr → Jul 2016 | primary viral infectious disease, respiratory tract infectious disorder | Medicago | Completed | No outcome recorded |
| Phase 2 | NCT02768805 | Mar → May 2016 | respiratory tract infectious disorder, viral infectious disease | Medicago | Completed | No outcome recorded |
| Phase 2 | NCT02307851 | Nov 2014 → Jun 2015 | influenza | Novavax | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT03739112 | Sep 2018 → May 2019 | respiratory tract infectious disorder, viral infectious disease | Medicago | Completed | No outcome recorded |
| Phase 3 | NCT03301051 | Aug 2017 → May 2018 | influenza | Medicago | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | quadrivalent VLP vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01991587 ↗ |
| Known as | Quadrivalent VLP Influenza Vaccine | “This Phase 3 study is intended to assess the efficacy of the Quadrivalent VLP Influenza Vaccine during the 2017-2018 influenza season in healthy adults 18 to 64 years of age.” NCT03301051 ↗ |
| Known as | QVLP | “In a phase 1-2 clinical trial, healthy adults received one intramuscular dose of a seasonal influenza plant-based quadrivalent virus-like particle (QVLP) vaccine or placebo.” PMID 26987887 ↗ Mar 2016 |
| Known as | QVLP vaccine | “Participants in the 18-64 study were randomly assigned (1:1) to receive either QVLP vaccine (30 μg haemagglutinin per strain) or placebo.” PMID 33065035 ↗ Oct 2020 |
| Modality | Vaccine | “Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults” NCT01991587 ↗ |
| Route | Intramuscular | “a single intramuscular injection of plant-based Seasonal Quadrivalent VLP Influenza Vaccine administered to healthy adults 18-49 years of age” NCT01991587 ↗ |